[Federal Register: December 1, 2003 (Volume 68, Number 230)]
[Notices]               
[Page 67171-67176]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01de03-77]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Practices To Improve Training Skills of Home Visitors

    Announcement Type: New.
    Funding Opportunity Number: PA 04053.
    Catalog of Federal Domestic Assistance Number: 93.136.
    Key Dates: ------------.
    Letter of Intent Deadline: December 31, 2003.
    Application Deadline: February 19, 2004.

I. Funding Opportunity Description

    Authority: This program is authorized under section 391 (a) of 
the Public Health Service Act (42 U.S.C. 280b (a)), as amended.

Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2004 funds for a cooperative agreement 
program to conduct a systematic examination of the impact of home 
visitor training and factors related to the implementation (i.e., 
competency of visitors providing services, adequate coverage of content 
according to a pre-specified protocol) of an existing efficacious or 
effective home visiting program on family outcomes of child 
maltreatment and risk behaviors for youth violence (e.g., poor parent-
child relations; harsh, lax, or inconsistent discipline). This program 
addresses the ``Healthy People 2010'' focus area of Injury and Violence 
Prevention.
    Measurable outcomes of the program will be in alignment with the 
following performance goal for the National Center for Injury 
Prevention and Control (NCIPC): Conduct a targeted program of research 
to reduce injury-related death and disability.

Research Objectives

    Home visiting programs to assist at-risk families have existed for 
more than a century and are widespread throughout the United States and 
Europe (United States General Accounting Office, 1990). Home-based 
programs have been reported to be effective in preventing child 
maltreatment (Guide to Community Preventive Services, 2002; MacLeod & 
Nelson, 2000; Roberts, 1997; Thornton et al., 2000) and have been 
recommended as a child maltreatment prevention strategy (Guide to 
Community Preventive Services, 2002). In addition, evaluations have 
suggested that home visiting programs may positively impact children's 
physical health and well-being (e.g., Bidgood & van de Sande, 1990; 
United States General Accounting Office, 1990). The literature suggests 
home visiting is a promising strategy to promote healthy family 
relationships and children's social, cognitive and character 
development, thereby decreasing children's risk for subsequent youth 
violence and delinquency (Thornton, Craft, Dahlberg, Lynch, & Baer, 
2000).
    However, effects of home visiting can be modest or short-lived 
(MacLeod & Nelson, 2000; Bidgood & van de Sande, 1990; Roberts, 1997), 
and the relative effectiveness of home visiting at preventing child 
maltreatment varies widely with the particular program being evaluated 
(Chaffin, 2001; Gomby, Culross, & Behrman, 1999; MacLeod & Nelson, 
2000; MacMillan, MacMillan, Offord, Griffith, & MacMillan, 1994; 
Guterman, 1997). For most home visiting programs, information on the 
quality and implementation of services is limited, if not altogether 
lacking, suggesting the need to systematically examine: (1) training of 
service providers and (2) program implementation, as these variables 
may be key to home visiting's effectiveness.
    Recommendations to improve the effectiveness of home visiting 
programs frequently include improved training, implementation, and 
quality and structure of services (e.g., Gomby et al., 1999; Roberts, 
1997; United States General Accounting Office, 1990).
    Research funded under this announcement is expected to address one 
of two research questions:
    (1) Do performance criteria measures; fidelity measures, or other 
training practices (separately or together) improve staff performance 
and family outcomes in home visiting programs? Performance criteria 
measures require trainees to demonstrate mastery of skills to pre-
determined standards. Fidelity measures require that those standards 
are maintained during follow-up observations, with retraining as needed 
to maintain the standards. Family outcomes relevant to this project 
would necessarily include but are not limited to incidents of child 
maltreatment, parenting behaviors, and children's behavioral, 
emotional, and cognitive adjustment.
    (2) What training practices improve or enhance paraprofessionals' 
performance compared to professionals' performance and family outcomes 
in home visiting programs? Paraprofessionals are individuals without 
advanced training in the fields of mental health or medicine, such as 
peer mentors whereas professionals are individuals with advanced 
training in the fields of mental health or medicine, such as master's 
level social workers, psychologists, nurses, etc.
    If a grantee chooses to respond to both questions, two separate 
applications should be submitted.

[[Page 67172]]

Funding Priority

    Public comments on the proposed Funding Priority are not being 
solicited due to insufficient time prior to the funding date. Funding 
Priorities will be given to programs that address one of the research 
questions, provide evidence of an existing home visiting program, and 
are consistent with the CDC NCIPC Injury Research Agenda (http://www.cdc.gov/ncipc
).

Funding Preferences

    Funding preference will be given to proposals that:
    [sbull] Provide more stringent and rigorous evaluation designs, and 
provide evidence of the capacity to develop a research design and 
methodology. A plan must be provided to evaluate the independent and 
combined impact of various factors related to training and program 
implementation on family outcomes.
    [sbull] Demonstrate expertise in development and evaluation of 
preventive interventions for child maltreatment or youth violence.
    [sbull] Provide evidence of the efficacy or effectiveness of an 
existing home visiting program for the prevention of child maltreatment 
and/or risk behaviors for youth violence.
    [sbull] Include plans for ensuring that the project is carried out 
as designed and the target community or population receives or has 
access to the intervention (i.e., program exposure).
    [sbull] Provide a data analysis plan that is appropriate to 
research design and hypotheses, the intervention, and data collection 
measures. Plan must anticipate and evaluate the effect of threats to 
the internal and external validity of the specified research design.
    [sbull] Target traditionally underserved communities.

Activities

    Awardee activities for this program are as follows:
    1. Develop and finalize the research design and methodology, data 
collection measures, methods, analyses, and disseminate the study 
results through publications and presentations.
    2. Obtain approval of the study protocol by the recipient's local 
IRB. Collaborate with CDC in the development of a research protocol for 
CDC Institutional Review Board (IRB) review.
    3. Develop a standardized established protocol (e.g., manual) for 
the delivery of services to clients in their homes that allows for 
documentation of the nature and quality of the services delivered. The 
proposed interventions of the home visiting protocol must reflect 
cultural sensitivity and responsiveness.
    4. Provide and evaluate a curriculum for the training of home 
visitors that allows for the examination of the impact of different 
training practices on trainees' skill and knowledge acquisition, 
competence, and delivery of services. The various training components 
or practices may be tested as a package, but should allow for 
dismantling of the individual effects of each component and should 
include documentation of training. The design should include adequate 
assessment and control for the pre-training characteristics of 
trainees, including trainees' personal attributes, knowledge, skills, 
and abilities.
    5. Collect data on program implementation. This may include direct 
observation of staff performance, supervisor ratings, and additional 
indirect measures.
    6. Collect data on the costs of training and implementation of the 
home visitation program.
    7. Conduct one site visit to meet with CDC staff in Atlanta on an 
annual basis.
    8. Complete all required reports as specified under ``Reporting 
Requirements'.
    In a cooperative agreement, CDC staff is substantially involved in 
the program activities, above and beyond routine grant monitoring.
    CDC Activities for this program are as follows:
    1. Provide scientific and programmatic consultation. CDC will 
collaborate with project staff on decision-analyses, research design 
and methodology, data collection and analyses, programmatic issues, and 
dissemination of the study results in publications and presentations.
    2. Assist in the development of a research protocol for 
Institutional Review Board (IRB) review by all cooperating institutions 
participating in the research project. The CDC IRB must review and 
approve the protocol initially and on at least an annual basis until 
the research project is completed.
    3. CDC staff will monitor and review scientific and operational 
accomplishments of the project through conference calls, site visits, 
and review of technical reports.

II. Award Information

    Type of Award: Cooperative Agreement. CDC involvement in this 
program is listed in the Activities section above.
    Fiscal Year Funds: FY 2004.
    Approximate Total Funding: $500,000.
    Approximate Number of Awards: Two.
    Approximate Average Award: $250,000.
    Floor of Award Range: $250,000.
    Ceiling of Award Range: $250,000.
    Anticipated Award Date: September 1, 2004.
    Budget Period Length: 12 months.
    Project Period Length: Five years.
    Throughout the project period, CDC's commitment to continuation of 
awards will be conditioned on the availability of funds, evidence of 
satisfactory progress by the recipient (as documented in required 
reports), and the determination that continued funding is in the best 
interest of the Federal Government.

III. Eligibility Information

    1. Eligible applicants: Applications may be submitted by public and 
nonprofit private and for profit organizations and by governments and 
their agencies, such as:
    [sbull] Public nonprofit organizations.
    [sbull] Private nonprofit organizations.
    [sbull] For profit organizations.
    [sbull] Small, minority, women-owned businesses.
    [sbull] Universities.
    [sbull] Colleges.
    [sbull] Research institutions.
    [sbull] Hospitals.
    [sbull] Community-based organizations.
    [sbull] Faith-based organizations.
    [sbull] Federally recognized Indian tribal governments.
    [sbull] Indian tribes.
    [sbull] Indian tribal organizations.
    [sbull] State and local governments or their Bona Fide Agents (this 
includes the District of Columbia, the Commonwealth of Puerto Rico, the 
Virgin Islands, the Commonwealth of the Northern Marianna Islands, 
American Samoa, Guam, the Federated States of Micronesia, the Republic 
of the Marshall Islands, and the Republic of Palau).
    [sbull] Political subdivisions of States (in consultation with 
States).
    A Bona Fide Agent is an agency/organization identified by the state 
as eligible to submit an application under the state eligibility in 
lieu of a state application. If you are applying as a bona fide agent 
of a state or local government, you must provide a letter from the 
state or local government as documentation of your status. Place this 
documentation behind the first page of your application form.
    2. Cost Sharing or Matching: Matching funds are not required for 
this program.
    3. Other Eligibility Requirements: If your application is 
incomplete or non-responsive to the requirements listed

[[Page 67173]]

below, it will not be entered into the review process. You will be 
notified that your application did not meet the submission 
requirements. The following applicant requirements are:
    [sbull] A principal investigator who has documented prior training 
and experience in conducting efficacy and effectiveness trials.
    [sbull] A principal investigator who has conducted research, 
published the findings in peer-reviewed journals, and has specific 
authority and responsibility to carry out the proposed project.
    [sbull] Demonstrated experience on the applicant's project team in 
conducting, evaluating, and publishing violence prevention research in 
peer-reviewed journals.
    [sbull] Effective and well-defined working relationships within the 
performing organization and with outside entities, which will ensure 
implementation of the proposed activities.
    [sbull] The requested funding amount should not be greater than the 
ceiling of the award range.
    [sbull] It is especially important to include an abstract that 
reflects the project's focus, because the abstract will be used to help 
determine the responsiveness of the application.

    Note: Title 2 of the United States Code section 1611 states that 
an organization described in section 501(c)(4) of the Internal 
Revenue Code that engages in lobbying activities is not eligible to 
receive Federal funds constituting an award, grant, or loan.

    4. Individuals Eligible To Become Principal Investigators: Any 
individual with the skills, knowledge, and resources necessary to carry 
out the proposed research is invited to work with their institution to 
develop an application for support. Individuals from underrepresented 
racial and ethnic groups as well as individuals with disabilities are 
always encouraged to apply for CDC programs.

IV. Application and Submission Information

1. Address To Request Application Package

    To apply for this funding opportunity, use application form PHS 398 
(OMB number 0925-0001 rev. 5/2001). Forms and instructions are 
available in an interactive format on the CDC Web site, at the 
following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm.
    Forms and instructions are also available in an interactive format 
on the National Institutes of Health (NIH) Web site at the following 
Internet address: http://grants.nih.gov/grants/funding/phs398/phs398.html
.
    If you do not have access to the Internet, or if you have 
difficulty accessing the forms online, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to 
you.

2. Content and Form of Application Submission

Letter of Intent (LOI)
    CDC requests that you send a LOI if you intend to apply for this 
program. Although the LOI is not required, not binding, and does not 
enter into the review of your subsequent application, your LOI will be 
used to gauge the level of interest in this program, and to allow CDC 
to plan the application review. Your LOI must be written in the 
following format:
    [sbull] Maximum number of pages: Two.
    [sbull] Font size: 12-point unreduced.
    [sbull] Single spaced.
    [sbull] Paper size: 8.5 by 11 inches.
    [sbull] Page margin size: One inch page.
    [sbull] Printed only on one side of page.
    [sbull] Written in English, avoid jargon.
    Your LOI must contain the following information:
    [sbull] Descriptive title of the proposed research.
    [sbull] Name, address, e-mail address, and telephone number of the 
Principal Investigator.
    [sbull] Names of other key personnel.
    [sbull] Participating institutions.
    [sbull] Number and title of this Program Announcement (PA).
Application
    Follow the PHS 398 application instructions for content and 
formatting of your application. For further assistance with the PHS 398 
application form, contact GrantsInfo, Telephone (301) 435-0714, E-mail: GrantsInfo@nih.gov. The Program Announcement Title and number must 
appear in the application.
    You must include a research plan with your application. The 
research plan should be no more than 25 pages.
    Your application will be evaluated on the criteria listed under 
Section V. Application Review Information, so it is important to follow 
them, as well as the Research Objectives and the Administrative and 
National Policy Requirements (AR's), in laying out your research plan.
    Your research plan should address activities to be conducted over 
the entire project period. The research plan should consist of the 
following information:
    1. Abstract. It is especially important to include an abstract that 
reflects the project's focus, because the abstract will be used to help 
determine the responsiveness of the application.
    2. Program Goals and Objectives. Describe the goals and objectives 
the proposed research is designed to achieve in the short and long 
term. Specific research questions and hypotheses should be included.
    3. Program Participants. Provide a justification and description of 
the specific population of families targeted, including the demographic 
and geographic characteristics of the community and/or neighborhood in 
which the intervention will take place. In addition, the proposal 
should provide evidence that the recipient has the capacity and 
community support necessary to successfully evaluate the training 
component of the home visiting program. Describe how the study 
sample(s) is defined. A description of how recruitment, retention and 
referral of participants will be handled should also be included.
    4. Intervention. Describe the proposed strategies or components of 
the plan for implementing the research. This should include a 
description of the training and intervention components (including 
training criteria and how fidelity of training and the home-visiting 
program will be assessed), and procedures.
    5. Evaluation Design. Describe the proposed design; methods and 
analysis plan for assessing the efficacy or effectiveness of the 
existing home-visiting program. The specific type of research method 
chosen should reflect the nature of the intervention, feasibility, and 
ethical considerations. Potential threats to the validity of the study 
should be described along with how such threats will be recognized and 
addressed. The status of all necessary measurement instruments should 
be described and include direct and indirect measures of child 
maltreatment and youth violence and/or risk for youth violence. If any 
materials are not extant, the methods and time frame for measure 
development, pilot testing, and validation should be given. For data 
collected from archival records (e.g., CPS records, school records, 
etc.) the proposal should discuss issues of accessibility, reliability, 
and validity of those data.
    6. Project Management. Provide evidence of the expertise, capacity, 
and support necessary to successfully implement and evaluate the impact 
of the program. Each existing or proposed staff position for the 
project should be described by job title, function, general duties, 
level of effort, and allocation of time. Management operation 
principles, structure, and organization should also be noted.

[[Page 67174]]

    7. Collaborative Efforts. List and describe the current and 
proposed collaborations with government, health, or youth agencies, 
community- or faith-based organizations, minority organizations, and 
other researchers. Include letters of support and memoranda of 
understanding that specify the nature of past, present, and proposed 
collaborations, and the products/services/activities that will be 
provided by and to the applicant.
    8. Data Sharing and release: Describe plans for the sharing and 
release of data (See AR-25 for additional information).
    9. Project Budget: Provide a detailed budget for each activity 
undertaken, with accompanying justification of all operating expenses 
that is consistent with the stated objectives and planned activities of 
the project. This announcement does not use the modular budget format.
    You are required to have a Dun and Bradstreet Data Universal 
Numbering System (DUNS) number to apply for a grant or cooperative 
agreement from the Federal government. Your DUNS number must be entered 
in item 11 of the face page of the PHS 398 application form. The DUNS 
number is a nine-digit identification number, which uniquely identifies 
business entities. Obtaining a DUNS number is easy and there is no 
charge. To obtain a DUNS number, access http://www.dunandbradstreet.com or 
call 1-866-705-5711. For more information, see the CDC Web site at 
http://www.cdc.gov/od/pgo/funding/pubcommt.htm.

3. Submission Dates and Times

    LOI Deadline Date: December 31, 2003.
    Application Deadline Date: February 19, 2004.
    Explanation of Deadlines: Applications must be received in the CDC 
Procurement and Grants Office by 4 p.m. eastern time on the deadline 
date. If you send your application by the United States Postal Service 
or commercial delivery service, you must ensure that the carrier will 
be able to guarantee delivery of the application by the closing date 
and time. If CDC receives your application after closing due to: (1) 
Carrier error, when the carrier accepted the package with a guarantee 
for delivery by the closing date and time, or (2) significant weather 
delays or natural disasters, you will be given the opportunity to 
submit documentation of the carriers guarantee. If the documentation 
verifies a carrier problem, CDC will consider the application as having 
been received by the deadline.
    This announcement is the definitive guide on application submission 
address and deadline. It supersedes information provided in the 
application instructions. If your application does not meet the 
deadline above, it will not be eligible for review, and will be 
discarded. You will be notified that your application did not meet the 
submission requirements.
    CDC will not notify you upon receipt of your application. If you 
have a question about the receipt of your application, first contact 
your courier. If you still have a question, contact the PGO-TIM staff 
at: 770-488-2700. Before calling, please wait two to three days after 
the application deadline. This will allow time for applications to be 
processed and logged.
4. Intergovernmental Review of Applications
    Executive Order 12372 does not apply to this program.
5. Funding Restrictions
    Restrictions, which must be taken into account while writing your 
budget, are as follows: None.
    If you are requesting indirect costs in your budget, you must 
include a copy of your indirect cost rate agreement. If your indirect 
cost rate is a provisional rate, the agreement must be less than 12 
months of age.
6. Other Submission Requirements
    LOI Submission Address: Submit your LOI by express mail delivery 
service, fax, or e-mail to: Robin Forbes, Centers for Disease Control 
and Prevention, National Center for Injury Prevention and Control, 4770 
Buford Hwy, NE., Mailstop K-62, Atlanta, GA 30341, Phone: 770-488-4037, Fax: 770-488-1662, E-mail: CIPERT@cdc.gov.
    Application Submission Address: Submit the original and five copies 
of your application by mail or express mail delivery service to: 
Technical Information Management-PA 04053, CDC Procurement and 
Grants Office, 2920 Brandywine Road, Atlanta, GA 30341.
    Applications may not be submitted electronically at this time.

V. Application Review Information

1. Criteria

    You are required to provide measures of effectiveness that will 
demonstrate the accomplishment of the various identified objectives of 
the cooperative agreement. Measures of effectiveness must relate to the 
performance goals stated in the ``Purpose'' section of this 
announcement. Measures must be objective and quantitative, and must 
measure the intended outcome. These measures of effectiveness must be 
submitted with the application and will be an element of evaluation.
    The goals of CDC-supported research are to advance the 
understanding of biological systems, improve the control and prevention 
of disease and injury, and enhance health. In the written comments, 
reviewers will be asked to evaluate the application in order to judge 
the likelihood that the proposed research will have a substantial 
impact on the pursuit of these goals. The scientific review group will 
address and consider each of the following criteria in assigning the 
application's overall score, weighting them as appropriate for each 
application. If the applicant proposes to address both research 
questions in a single project, the ability of the project to address 
each of the research questions will be evaluated separately. The 
application does not need to be strong in all categories to be judged 
likely to have major scientific impact and thus deserve a high priority 
score. For example, an investigator may propose to carry out important 
work that by its nature is not innovative, but is essential to move a 
field forward.
    The criteria are as follows:
    Significance: Does this study address an important problem? If the 
aims of the application are achieved, how will scientific knowledge be 
advanced? What will be the effect of these studies on the concepts or 
methods that drive this field?
    Approach: Are the conceptual framework, design, methods, and 
analyses adequately developed, scientifically rigorous, well-
integrated, and appropriate to the aims of the project? Does the 
applicant acknowledge potential problem areas and consider alternative 
tactics?
    Innovation: Does the project employ novel concepts, approaches or 
methods? Are the aims original and innovative? Does the project 
challenge existing paradigms or develop new methodologies or 
technologies?
    Investigator: Is the investigator appropriately trained and well 
suited to carry out this work? Is the work proposed appropriate to the 
experience level of the principal investigator and other researchers 
(if any)?
    Environment: Does the scientific environment in which the work will 
be done contribute to the probability of success? Does the proposed 
research take advantage of unique features of the scientific 
environment or employ useful collaborative arrangements? Is there 
evidence of institutional support?
    Additional Review Criteria: In addition to the above criteria, the

[[Page 67175]]

following items will be considered in the determination of scientific 
merit and priority score:
    1. Intervention. Is the potential efficacy or effectiveness of the 
proposed program within the target population or community 
theoretically justified and supported with epidemiological, 
methodological, and behavioral research? How feasible is the 
implementation of the efficacy or effectiveness study as proposed?
    2. Dissemination. Are there plans for the dissemination of findings 
and the sharing and release of data? Are these plans well articulated? 
Do the plans include provision for disseminating findings to 
stakeholders outside of academia?
    Protection of Human Subjects from Research Risks: Does the 
application adequately address the requirements of title 45 CFR part 46 
for the protection of human subjects? Not scored; however, an 
application can be disapproved if the research risks are sufficiently 
serious and protection against risks is so inadequate as to make the 
entire application unacceptable.
    Inclusion of Women and Minorities in Research: Does the application 
adequately address the CDC Policy requirements regarding the inclusion 
of woman, ethnic, and racial groups in the proposed research? This 
includes: (1) The proposed plan for the inclusion of both sexes and 
racial and ethnic minority populations for appropriate representation; 
(2) The proposed justification when representation is limited or 
absent; (3) A statement as to whether the design of the study is 
adequate to measure differences when warranted; and (4) A statement as 
to whether the plans for recruitment and outreach for study 
participants include the process of establishing partnerships with 
community(ies) and recognition of mutual benefits.
    Inclusion of Children as Participants in Research Involving Human 
Subjects: The NIH maintains a policy that children (i.e., individuals 
under the age of 21) must be included in all human subjects research, 
conducted or supported by the NIH, unless there are scientific and 
ethical reasons not to include them. This policy applies to all initial 
(Type 1) applications submitted for receipt dates after October 1, 
1998.
    All investigators proposing research involving human subjects 
should read the ``NIH Policy and Guidelines'' on the inclusion of 
children as participants in research involving human subjects that is 
available at http://grants.nih.gov/grants/funding/children/children.htm
.
    Budget: The reasonableness of the proposed budget and the requested 
period of support in relation to the proposed research.

2. Review and Selection Process

    Applications will be reviewed for completeness by the Procurement 
and Grants Office (PGO) and for responsiveness of the eligibility 
information by the NCIPC. Incomplete applications and applications that 
are non-responsive to the eligibility criteria will not advance through 
the review process. You will be notified that the application did not 
meet submission requirements.
    Applications that are complete and responsive to the PA will be 
subjected to a preliminary evaluation (streamline review) by a peer 
review committee, the Initial Review Group (IRG), convened by NCIPC, to 
determine if the application is of sufficient technical and scientific 
merit to warrant further review by the IRG. CDC will withdraw from 
further consideration applications judged to be noncompetitive and 
promptly notify the principal investigator or program director and the 
official signing for the applicant organization. Those applications 
judged to be competitive will be further evaluated by a dual review 
process.
    1. The primary review will be a peer review conducted by the IRG. 
All applications will be reviewed for scientific merit in accordance 
with the review criteria listed above. Applications will be assigned a 
priority score based on the National Institutes of Health (NIH) scoring 
system of 100-500 points.
    2. The secondary review will be conducted by the Science and 
Program Review Subcommittee (SPRS) of NCIPC's Advisory Committee for 
Injury Prevention and Control (ACIPC). The ACIPC Federal agency experts 
will be invited to attend the secondary review, and will receive 
modified briefing books (i.e., abstracts, strengths and weaknesses from 
summary statements, and project officer's briefing materials). ACIPC 
Federal agency experts will be encouraged to participate in 
deliberations when applications address overlapping areas of research 
interest, so that unwarranted duplication in federally funded research 
can be avoided and special subject area expertise can be shared. The 
NCIPC Division Associate Directors for Science (ADS) or their designees 
will attend the secondary review in a similar capacity as the ACIPC 
Federal agency experts to assure that research priorities of the 
announcement are understood and to provide background regarding current 
research activities. Only SPRS members will vote on funding 
recommendations, and their recommendations will be carried to the 
entire ACIPC for voting by the ACIPC members in closed session. If any 
further review is needed by the ACIPC, regarding the recommendations of 
the SPRS, the factors considered will be the same as those considered 
by the SPRS.
    The committee's responsibility is to develop funding 
recommendations for the NCIPC Director based on the results of the 
primary review, the relevance and balance of proposed research relative 
to the NCIPC programs and priorities, and to assure that unwarranted 
duplication of federally-funded research does not occur. The secondary 
review committee has the latitude to recommend to the NCIPC Director, 
to reach over better-ranked proposals in order to assure maximal impact 
and balance of proposed research. The factors to be considered will 
include:
    a. The results of the primary review including the application's 
priority score as the primary factor in the selection process.
    b. The relevance and balance of proposed research relative to the 
NCIPC programs and priorities.
    c. The significance of the proposed activities in relation to the 
priorities and objectives stated in ``Healthy People 2010,'' the 
Institute of Medicine report, ``Reducing the Burden of Injury,'' and 
the ``CDC Injury Research Agenda.''
    All awards will be determined by the Director of the NCIPC based on 
priority scores assigned to applications by the IRG, recommendations by 
the secondary review committee, e.g., ACIPC, consultation with NCIPC 
senior staff, and the availability of funds.

VI. Award Administration Information

1. Award Notices

    Successful applicants will receive a Notice of Grant Award (NGA) 
from the CDC Procurement and Grants Office. The NGA shall be the only 
binding, authorizing document between the recipient and CDC. The NGA 
will be signed by an authorized Grants Management Officer, and mailed 
to the recipient fiscal officer identified in the application.

2. Administrative and National Policy Requirements

45 CFR Part 74 or 92
    For more information on the Code of Federal Regulations, see the 
National Archives and Records Administration at the following Internet 
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
    The following additional requirements apply to this project:


[[Page 67176]]


[sbull] AR-1 Human Subjects Requirements
[sbull] AR-2 Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
[sbull] AR-8 Public Health System Reporting Requirements
[sbull] AR-9 Paperwork Reduction Act Requirements
[sbull] AR-10 Smoke-Free Workplace Requirements
[sbull] AR-11 Healthy People 2010
[sbull] AR-12 Lobbying Restrictions
[sbull] AR-13 Prohibition on Use of CDC Funds for Certain Gun Control 
Activities
[sbull] AR-14 Accounting System Requirements
[sbull] AR-15 Proof of Non-Profit Status
[sbull] AR-21 Small, Minority, and Women-Owned Business
[sbull] AR-22 Research Integrity
[sbull] AR-23 States and Faith-Based Organizations
[sbull] AR-24 Health Insurance Portability and Accountability Act 
Requirements
[sbull] AR-25 Release and Sharing of Data

    Starting with the December 1, 2003, receipt date, all NCIPC funded 
investigators seeking more than $250,000 in total costs in a single 
year are expected to include a plan describing how the final research 
data will be shared/released or explain why data sharing is not 
possible. Details on data sharing/release, including the timeliness and 
name of the project data steward, should be included in a brief 
paragraph immediately following the Research Plan Section of the PHS 
398 form. References to data sharing/release may also be appropriate in 
other sections of the application (e.g., background and significance, 
human subjects requirements, etc.) The content of the data sharing/
release plan will vary, depending on the data being collected and how 
the investigator is planning to share the data. The data sharing/
release plan will not count towards the application page limit and will 
not factor into the determination scientific merit or priority scores. 
Investigators should seek guidance from their institutions, on issues 
related to institutional policies, local IRB rules, as well as local, 
state and Federal laws and regulations, including the Privacy Rule.
    Further detail on the requirements for addressing data sharing in 
applications for NCIPC funding may be obtained by contacting NCIPC 
program staff or visiting the NCIPC Internet Web site at http://www.cdc.gov/ncipc/osp/sharing_policy.htm
.
    For more information on the Code of Federal Regulations, see the 
National Archives and Records Administration at the following Internet 
address: http://www.access.gpo.gov/nara/cfr-table-search.html.

3. Reporting

    You must provide CDC with an original, plus two copies of the 
following reports:
    1. Interim progress report, (PHS 2590, OMB Number 0925-0001, rev. 
5/2001) no less than 90 days before the end of the budget period. The 
progress report will serve as your non-competing continuation 
application, and must contain the following elements:
    a. Current Budget Period Activities and Objectives.
    b. Current Budget Period Financial Progress.
    c. New Budget Period Program Proposed Activity Objectives.
    d. Detailed Line-Item Budget and Justification.
    e. Additional Requested Information.
    f. Measures of Effectiveness.
    2. Financial status report, no more than 90 days after the end of 
the budget period.
    3. Final financial and performance reports, no more than 90 days 
after the end of the project period.
    At the completion of the project, the grant recipient will submit a 
brief (2500 to 5000 words) summary highlighting the findings and their 
implications for injury prevention programs, policies, etc., that 
includes a plan for dissemination of the research findings. The results 
dissemination plan will include publications in peer-reviewed journals 
and other methodologies for sharing results with stakeholders outside 
of academic settings (e.g., state and community groups, public health 
injury prevention practitioners).
    These reports must be sent to the Grants Management Specialist 
listed in the ``Agency Contacts'' section of this announcement.

VII. Agency Contacts

    For general questions about this announcement, contact: Technical 
Information Management Section, CDC Procurement and Grants Office, 2920 
Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-2700.
    For scientific/research program technical assistance, contact: 
Linda Anne Valle, PhD, Prevention Development and Evaluation Branch, 
Division of Violence Prevention, National Center for Injury Prevention 
and Control, 4770 Buford Hwy, MS K-60, Atlanta, GA 30341, Telephone: 770-488-4297, E-mail: adv2@cdc.gov.
    For questions about peer review, contact: Gwen Cattledge, Science 
Review Administrator, National Center for Injury Prevention and 
Control, 4770 Buford Hwy, Mailstop K-02, Atlanta, GA 30341, Phone: 770-488-1430, E-mail: gxc8@cdc.gov.
    For budget assistance, contact: Jim Masone, Grants Management (or 
Contract) Specialist, CDC Procurement and Grants Office, 2920 
Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-2736, E-mail: zft2@cdc.gov.

VIII. Other Information

References

    Chaffin, M. (2001). Programs to prevent child abuse and neglect. 
Newsletter of the Society of Pediatric Psychology, 25(3), 6-7.
    Gomby, D. S., Culross, P. L., & Behrman, R. E. (1999). Home 
visiting: Recent program evaluations: Analysis and recommendations. 
Future of Children, 9(1), 4-26.
    Guide to Community Preventive Services. New findings prove early 
childhood home visitation prevents child maltreatment. Retrieved 
October 17, 2002 from http://www.thecommunityguide.org.
    Guterman, N. B. (1997). Early prevention of physical child abuse 
and neglect: Existing evidence and future directions. Child 
Maltreatment, 2, 12-34.
    MacLeod, J., & Nelson, G. (2000). Programs for the promotion of 
family wellness and the prevention of child maltreatment: A meta-
analytic review. Child Abuse & Neglect, 24, 1127-1149.
    MacMillan, H. L., MacMillan, J. H., Offort, D. R., Griffith, L., 
& MacMillan, A. (1994). Primary prevention of child physical abuse 
and neglect: A critical review. Part I. Journal of Child Psychology 
and Psychiatry, 35, 835-856.
    Roberts, R. (1997). Preventing child abuse and neglect through 
home visiting: Informing practice with research. The APSAC Advisor, 
10(1), 7-9.
    Thornton, T. N., Craft, C. A., Dahlberg, L. L., Lynch, B. S., 
Baer, K. (2000). Best practices of youth violence prevention: A 
sourcebook for community action. Atlanta, GA: Centers for Disease 
Control and Prevention, National Center for Injury Prevention and 
Control.
    United States General Accounting Office, (1990). Home visiting: 
A promising strategy for at-risk families. (GAO/HRD Publication No. 
90-83). Gaithersburg, MD: U.S. General Accounting Office.

    Dated: November 24, 2003.
Edward Schultz,
Acting Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 03-29788 Filed 11-28-03; 8:45 am]

BILLING CODE 4163-18-P